Nanoviricides, Inc. financial data

Symbol
NNVC on NYSE
Industry
Pharmaceutical Preparations
Location
1 Controls Drive, Shelton, Connecticut
State of incorporation
Nevada
Fiscal year end
June 30
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 752 % -73.2%
Debt-to-equity 12.3 %
Return On Equity -74.7 % -127%
Return On Assets -66.5 % -107%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.8M shares +1.27%
Common Stock, Shares, Outstanding 11.8M shares +1.26%
Entity Public Float 12.2M USD -70%
Common Stock, Value, Issued 118 USD -99%
Weighted Average Number of Shares Outstanding, Basic 11.8M shares +1.23%
Weighted Average Number of Shares Outstanding, Diluted 11.8M shares +1.23%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.17M USD +54.1%
General and Administrative Expense 2.63M USD +9.3%
Operating Income (Loss) -9.8M USD -38.8%
Nonoperating Income (Expense) 293K USD +12.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.97M USD -25.3%
Net Income (Loss) Attributable to Parent -9.51M USD -39.9%
Earnings Per Share, Basic -0.81 USD/shares -39.7%
Earnings Per Share, Diluted -0.81 USD/shares -39.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.26M USD -66.3%
Assets, Current 3.52M USD -64.6%
Property, Plant and Equipment, Net 7.6M USD -8.3%
Intangible Assets, Net (Excluding Goodwill) 327K USD -2.46%
Assets 11.5M USD -38.3%
Employee-related Liabilities, Current 22.4K USD
Accrued Liabilities, Current 259K USD +514%
Liabilities, Current 813K USD +133%
Liabilities 813K USD
Retained Earnings (Accumulated Deficit) -137M USD -7.46%
Stockholders' Equity Attributable to Parent 10.7M USD -41.6%
Liabilities and Equity 11.5M USD -38.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.17M USD -13.4%
Net Cash Provided by (Used in) Financing Activities -94.8K USD +59.6%
Net Cash Provided by (Used in) Investing Activities -152K USD +53.2%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 11.8M shares +1.26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.26M USD -66.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 37.4M USD +2.42%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 37.4M USD +2.42%
Depreciation 749K USD +1.45%
Payments to Acquire Property, Plant, and Equipment 8.29K USD -81.4%
Property, Plant and Equipment, Gross 14.9M USD +0.41%
Deferred Tax Assets, Operating Loss Carryforwards 28M USD +3.07%
Current Income Tax Expense (Benefit) 0 USD
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 148M USD +1.33%
Amortization of Intangible Assets 2.07K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 44K USD
Interest Expense 13.3K USD +14065%